By Francis Van Parys, Vice President Commercial, Asia-Pacific, Cytiva.
When we look back in years to come at the global response to the pandemic, the word “collaboration” is likely to be something that sticks out. While some have criticized the perceived lack of cooperation — whether that be cross-industry, public-private or country-to-country — the fact that terms like Pfizer-BioNTech and Oxford-AstraZeneca have become household names around the world highlights the importance that collaboration has played in the global response.
In a recent post, I wrote about the launch of the Cytiva Global Biopharma Resilience Index, which we have developed together…
2020 is ending with a special milestone — the two-thousandth ÄKTA device has been successfully installed in Korea. Bae Jin Seok is the Korea Service team leader and the engineer who installed and tested the first ÄKTA Explorer in Korea in 1996. The ÄKTA anniversary coincides with a personal one for Jin Seok, who celebrates 30 years of working for what is now Cytiva!
Jin Seok joined Pharmacia as a service engineer in 1991, but he never expected that he would stay in the same organization for the rest of his career. With so much knowledge to learn, great customers…
By Klara-Maria Mach
My husband Gustav had returned home to Uppsala, Sweden from a ski trip in the Austrian Alps a week before my symptoms started. Around that time, there was hardly any information about the coronavirus in the Swedish media, which gave us a false sense of security. Everything was too new to grasp and happening too fast to understand its severity.
The two days after my husband returned from Austria were completely normal. I went to work, trained in the gym, cooked meals — the usual stuff. But on the third day, my husband called me as soon…
By Gunnar Malmquist, Principal Scientist at Cytiva
People often call me a “rare bird”. In today’s job-hopping culture, it’s no wonder people get baffled when they encounter company veterans like me. In Sweden alone, people tend to change their workplace every five years — something that hasn’t changed since the late 1980s, according to the Swedish Bureau of Central Statistics. With the boom of the life sciences industry, it is estimated that around 67% of professionals are likely to seek a new job in the next 12 months.
I am a Principal Scientist at Cytiva (formerly known as GE Healthcare…
You say innovation, I say blah. It’s overused and under-demonstrated. But you recognize it when you see it, and when you meet someone who crackles with energy, you know you’ve found a possible source of innovation.
I had that feeling when I met Tobias Degsell. Our first encounter with him was to prepare for an internal event — celebrating the 60th anniversary of our product Sephadex (Link and photo) in Uppsala, Sweden. He was quiet in the meeting, and I admit I thought, “hm. Typical, reserved Swede.” …
Cell cultures, bioreactors, peptides, macromolecules. You can visualize the dance of the bio-molecules, how they bond, and how they form intricate interactions in our bodies. You can see the protein forming. You start envisioning its engineering, until it becomes the targeted therapy that can be delivered to a patient suffering from a life-threatening disease. You are not new to biotechnology.
But if peptides, macromolecules, and proteins sound like words coming straight out of a chemistry lab, buzzing in your ear and triggering your curiosity — then you have come to the right place. You are about to…
Do you ever go back to your notes from a trade show or a keynote and remember what was said? I rarely do, but to prepare for our most recent episode of our podcast Discovery Matters, I was happy to find what I had jotted down months earlier.
Back in Philadelphia in early June, Conor McKechnie, our Chief Marketing Officer, and I were sitting next to each other listening to a keynote about microbiomes. He’s obsessed; I’m only interested. I scribbled phrases like:
“The best medicine is already inside us.”
“2lbs of bacteria in our gut!”
I didn’t know anything about the town of Framingham one year ago. But as I rode in a cab with a colleague on the way to our Marlborough offices from the Boston airport, we drove under the road sign that said: “Framingham.”
Conor said: “You know about the Heart Study, right?”
No, I didn’t know about the world’s longest-running study of heart health. 70 years strong — and the reason we know that what we eat makes a difference to our tickers. Seemed like a good topic for our podcast, Discovery Matters.
You can listen on Apple…
During a lively lunch chat about the popularity of wearable fitness trackers, the curious question came up: with all this data we are generating, what if we were able to do it 50–70 years ago — where would medicine and healthcare be now?
Hearing the question Dodi immediately remembered The Framingham Heart Study. Its objective was to identify the common factors or characteristics that contribute to cardiovascular disease (CVD) by following its development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD or suffered a…
A pandemic starts with a picnic. But can pandemics be prevented without cancelling feel-good gatherings?
Enter Artificial Intelligence into the world of healthcare and life sciences. Dodi meets up with an expert panel on the topic and gets examples of the real potential of this very trendy topic.
Listen to Discovery Matters podcast on your favorite podcast platform:
Insights on matters of discovery that advance life sciences. Brought to you by creatives, scientists, and leaders at Cytiva.